Working… Menu

Gene Therapy Study in Severe Haemophilia A Patients (270-201)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02576795
Recruitment Status : Active, not recruiting
First Posted : October 15, 2015
Last Update Posted : January 22, 2021
Information provided by (Responsible Party):
BioMarin Pharmaceutical